F/M Emerald Life Sciences Innovation ETF (LFSC)
NASDAQ: LFSC · Real-Time Price · USD
45.33
-0.04 (-0.09%)
At close: Sep 11, 2026, 4:00 PM EDT
45.27
-0.06 (-0.13%)
After-hours: Sep 11, 2026, 7:30 PM EDT

LFSC Holdings Information

LFSC is an equity ETF with a total of 40 individual holdings. The top holdings are Travere Therapeutics stock at 8.43%, Spyre Therapeutics at 7.58%, Cogent Biosciences at 7.01%, LivaNova at 6.50%, and Corcept Therapeutics at 6.46%.

Total Holdings
40
Top 10 Percentage
56.66%
Asset Class
Equity
ETF Category
Health
Assets
127.64M
PE Ratio
n/a

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1TVTXTravere Therapeutics, Inc.8.43%175,837
2SYRESpyre Therapeutics, Inc.7.58%94,334
3COGTCogent Biosciences, Inc.7.01%232,933
4LIVNLivaNova PLC6.50%104,248
5CORTCorcept Therapeutics Incorporated6.46%74,626
6GHGuardant Health, Inc.5.86%46,034
7MIRMMirum Pharmaceuticals, Inc.4.67%61,188
8CYTKCytokinetics, Incorporated3.62%62,018
9BLLNBillionToOne, Inc.3.34%44,406
10AXSMAxsome Therapeutics, Inc.3.20%19,328
11UTHRUnited Therapeutics Corporation3.19%8,073
12MANEVeradermics, Incorporated3.08%36,632
13NKTRNektar Therapeutics3.07%52,399
14SVRASavara Inc.2.95%670,578
15TMDXTransMedics Group, Inc.2.90%43,148
16DNTHDianthus Therapeutics, Inc.2.79%32,174
17TRVITrevi Therapeutics, Inc.2.68%195,954
18VRDNViridian Therapeutics, Inc.2.42%137,260
19ICUIICU Medical, Inc.2.31%16,711
20PVLAPalvella Therapeutics, Inc.2.13%17,766
21CRVSCorvus Pharmaceuticals, Inc.1.98%170,268
22TWSTTwist Bioscience Corporation1.78%18,382
23CBLLCeriBell, Inc.1.61%91,004
24HNGEHinge Health, Inc.1.21%18,114
25GMEDGlobus Medical, Inc.1.11%16,742
Showing 25 of 40 holdings
Subscribe to see the full list
As of Aug 12, 2026